title: Determination of optimal protein contents for a protein restriction diet in type 2 diabetic patients with microalbuminuria.
abstract: To establish the method by which the optimal dietary protein content for type 2 diabetic patients with nephropathy could be determined, dietary protein content was reduced in gradated steps and renal function was evaluated at the completion of each diet. Eight type 2 diabetic patients with microalbuminuria were examined in this study. Renal function, urinary albumin excretion rate (AER) and urinary excretion rates of prostaglandins were evaluated at the completion of each of three consecutive one-week dietary periods where the protein content was 1.2, 0.8 and 0.6 g x kg Body Weight (BW)(-1) x day(-1) on the first, second and third week, respectively. Filtration fraction (FF), AER and urinary excretion rates of prostaglandin E2 and 6-keto-prostaglandin F1alpha significantly decreased in response to reduced dietary protein content from 1.2 to 0.8 g x kg BW(-1) x day(-1). No additional decreases in FF, AER and urinary excretion rates of these two prostaglandins were obtained after the 0.6 g x kg BW(-1) x day(-1) low protein diet period. The method evaluating renal hemodynamics at the completion of several consecutive one-week dietary periods was confirmed to be useful to determine the optimal protein contents in type 2 diabetic patients with nephropathy. The result showed that the optimal protein content in type 2 diabetic patients with microalbuminuria was 0.8 g x kg BW(-1) x day(-1) and protein restriction of less than 0.8 g x kg BW(-1) x day(-1) was not necessary for patients with this stage of diabetic nephropathy. A part of reasons in which FF decreased after reduced protein content in diet may be due to decreased prostaglandins production in the kidneys.
authors.affiliation: Division of Geriatric Medicine, Akita University Hospital, Japan. narita@med.akita-u.ac.jp
authors.forename: T
authors.initials: T
authors.lastname: Narita
authors.forename: J
authors.initials: J
authors.lastname: Koshimura
authors.forename: H
authors.initials: H
authors.lastname: Meguro
authors.forename: H
authors.initials: H
authors.lastname: Kitazato
authors.forename: H
authors.initials: H
authors.lastname: Fujita
authors.forename: S
authors.initials: S
authors.lastname: Ito
mesh_terms: D000368:Aged; D000419:Albuminuria / Q000178:diet therapy* / Q000209:etiology / Q000503:physiopathology; D001786:Blood Glucose / Q000378:metabolism; D001806:Blood Urea Nitrogen; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000178:diet therapy*; D018753:Diet, Protein-Restricted; D004044:Dietary Proteins / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D011453:Prostaglandins / Q000652:urine; D012079:Renal Circulation / Q000502:physiology
chemical_list: D001786:Blood Glucose; D004044:Dietary Proteins; D011453:Prostaglandins